why choose us

First received: October 12, 2023

Clinical Trial: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Multi-center, Open-label, Single-arm Study to Assess the Safety of Apremilast (AMG 407) in Pediatric Participants From 6 Through 17 Years of Age With Mild to Moderate Plaque Psoriasis

Brief Summary: The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 17 years) with mild to moderate plaque psoriasis.

Read more